Gsa Capital Partners LLP Nkarta, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$3.37 - $6.3 $3,353 - $6,268	-995 Reduced 0.94%	104,935 $372,000
Q4 2022 Feb 13, 2023	BUY	$5.14 - $14.35 $544,480 - $1.52 Million	105,930 New	105,930 $635,000
Q2 2022 Aug 09, 2022	SELL	$7.77 - $19.44 $148,647 - $371,906	-19,131 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$8.66 - $14.99 $3,325 - $5,756	384 Added 2.05%	19,131 $218,000
Q4 2021 Feb 14, 2022	BUY	$12.79 - $26.88 $239,774 - $503,919	18,747 New	18,747 $288,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.